(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TERAPIA DE COMBINAÇÃO PARA TRATAR CRESCIMENTO CELULAR ANORMAL

Em AnáliseInvention PatentPCT · US2022078771

Application data

Invention Patent TERAPIA DE COMBINAÇÃO PARA TRATAR CRESCIMENTO CELULAR ANORMAL de VERASTEM, INC. — IPC A61K 31/352
Invention Patent TERAPIA DE COMBINAÇÃO PARA TRATAR CRESCIMENTO CELULAR ANORMAL de VERASTEM, INC. — IPC A61K 31/352. Drawing published by the INPI in the Industrial Property Gazette.

Number

112024008111

Type

Invention Patent

Filing

10/27/2022

Publication

08/13/2024

PCT

US2022078771

Progress at the INPI

  1. Filing10/27/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 10/27/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 08/13/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

VERASTEM, INC.

US

See this company's full portfolio

Inventors

J. P. (pessoa física)

US

S. C. (pessoa física)

US

S. C. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

63/272,899 · 10/28/2021

Abstract

TERAPIA DE COMBINAÇÃO PARA TRATAR CRESCIMENTO CELULAR ANORMAL. A presente invenção se refere, em parte, a métodos, compostos e composições de um inibidor BRAF V600, um inibidor pan-RAF, um inibidor CRAF ou um inibidor RAF em combinação com um inibidor duplo RAF/MEK, para tratar o crescimento celular anormal (por ex., câncer).

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

08/13/2024

RPI 2797

Alteração de dados cadastrais

#1.1

05/07/2024

RPI 2783

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.